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reimbursement decisions. I would recommend it for reading by all
vascular specialists.
An operating room database yielded the duration of time per
open or endovascular procedure and the data was cross referenced
with the reimbursement RVU monetary values to give the results
of dollars per hour per procedure. To no one’s surprise, endovas-
cular procedures pay better than open vascular surgical cases,
especially as the complexity of open cases increases. To the authors’
credit, they stick strictly to the facts and do not attempt to
politicize or give their personal opinions.
To keep this short, I have three questions of Dr Martin.
First, you explain and demonstrate in Fig 2 that Specialty
Society RVS Committees have input for reimbursement updates.
Which society represented and represents vascular surgery? In
other words, were vascular surgeons consulted to set the RVUs and
updates or did general surgeons assign values to our work?
Second, the Harvard Project to set resource-based relative
value scale was completed in 1992 and your first reference dealing
with vascular surgery RBRVS is 1993. Can you further explain how
the Harvard Project gathered data and why was it used?
Last, unfortunately I am now going to have to ask you for your
opinion. This article looks at reimbursement in the fee for service
world of today, but there could be a large and fundamental change
in the world of tomorrow. Therefore, what needs to be done to
allow and ensure quality vascular care with appropriately assigned
reimbursement for today’s vascular specialist?
I would like to thank Dr Martin for timely receipt of the
manuscript and the Association for the privilege of the floor.
Dr Martin. Thank you, Gene. I actually will answer the first
two questions together. If you look at the history of this system, it
started out as a project from the Harvard School of Public Health.
It was intended to tackle the issue of rising federal expenditures for
medical care yet provide fair payment for similar services across
extremity endovascular procedure of the same duration? More-specialties. It was supported by the AMA and ultimately funded by
Health Care Finance Administration. The data for a limited num-
ber of specialties were obtained by sending surveys to a large
number of physicians evaluating the work for various services
including time and intensity. There were a limited number of
specialties for which detailed data was available in the initial analysis
and this did not include vascular surgeons. The vascular RVUwere
obtained by extrapolation from those procedures included in the
original work. In 1997, our joint societies reported a detailed
review of vascular codes. Hugh Trout is here today and was part of
that task force. That group came to the conclusion that many of the
vascular codes were undervalued and corrections were made. It is
also important to understand the way this process works and the
ramifications of changes, it is like a seesaw. Because of the Budget
Reduction Act, everything has to balance, so if some codes were
valued up, other codes were valued down. There is this constant
push pull of these RVUs balancing out reimbursement. This is
what really poses the challenge in this system; all of these groups
are competing for a fixed target. As to your last question, two
things, first, my partner, Jon Hupp, asked me as we discussed this
project “Do you really want to stand up there on the podium and
present this? I suspect people are going to start shooting you for
putting this data out there.” I think this data is provocative but I
believe it is useful as long as you keep it in context. Do I think there
are some procedures that we are paid handsomely for? The answer
is yes, but they are equally balanced from those that I think we are
grossly underpaid. An overriding question one might ask; is there
a defined fee we should get paid per hour and should it be
constant? That is a difficult question to answer, but my impression
is that there are so many variables that a single figure cannot be
universally applied. What is clear is that better time data from
studies like this may rectify some of the inequalities that are clearly
identified in this study and the real value of this work is a demon-
stration that accurate time data is possible.INVITED COMMENTARYThomas F. O’Donnell, MD, Boston, Mass
Martin and colleagues’ article explores how well the Resource
Based Relative Value Scale (RBRVS) compensates vascular sur-
geons for open and endovascular (ENDO) procedures, based on
data gathered over a year of practice. In addition, the authors
provide “real world” documentation on current revenue genera-
tion in a vascular practice from these procedures. Certain condi-
tions apply to the data: 1) the authors’ group of three vascular
surgeons and one cardiologist practice in a “vascular center” at a
non-university based hospital without residents; 2) the data fo-
cuses only on revenue from operating room (OR)/catheterization
(interventional) suite-based procedures. Physician reimbursement
from office-based procedures, evaluation and management visits,
hospital consults, bed-side procedures, or vascular laboratory is not
included in the analysis; 3) no relative value unit (RVU) produc-
tivity or expense data is provided.
The revenue data has been normalized by procedure into a
dollar per hour format, which reflects not only the procedure time
($/HR.PROC), but it also is combined with the pre- and postop-
erative care – $/total care. As a result of their analysis, the authors
question the validity of the RBRVS process. Except for examples in
their discussion, the authors fail to report any data, however, on the
standard metric, RVU, for assessing physician productivity in
relation to net revenue for an individual procedure or for total net
revenue for a vascular surgeon. The authors favor time as the
metric for physician productivity. While time is the major driver
(70%) of the work RVU (wRVU), which comprises one-half of the
total RVU, focusing on time alone ignores the intensity dimension
(mental effort and judgment, technical skill, physical effort, and
stress) of a procedure. Is a 1.5 hour amputation the same as a lowerover, the time to perform a procedure can be quite variable from
surgeon to surgeon, so that the more expeditious surgeon is
reimbursed at a higher hourly rate for a procedure (Table). It is
difficult to make an argument for increased reimbursement with-
out emphasizing the complexity of the procedure.
To emphasize these points, I compared our own financial
analysis presented at the New England Vascular Society in Septem-
ber 2007 to the current paper.1 Our review was initiated by the
dramatic 16% increase in infrainguinal procedures over the decade,
but with a decided shift from open procedures (down 6.2%) to an
endovascular approach.2 To assess the impact of a predominantly
endovascular approach on physician revenue (like Martin’s study –
actual collections) from infrainguinal procedures, we reviewed our
experience with over 250 open procedures and 385 endovascular
procedures and analyzed a random sample from each group.
Although the collection per case for ENDO procedures was
comparable between the two studies, Martin’s study had a much
Table.
Hours* RVU $/RVU Col/Case $/HR.PROC
Endo T 2.82 26.08 $47.35 $1235 $437
Endo A 1.51 $1072 $610
Open T 5.03 34.97 $43.40 $1518 $301
Open A 3.7 $1560 $292
A, Current paper; Col, collection; Endo, endovascular; Proc, procedure;
T, Tufts.
*Procedure time.
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ENDO, which is directly related to the shorter procedure time of
1.3 hour. Despite a lower RVU (ENDO  26.08) than open
(34.97), the $/RVUwas higher in our study for ENDO than open
procedures. This reflects the better reimbursement for the physi-
cian’s work effort for ENDO. There was little difference, however,
in $/HR.PROC for open cases between the two studies. Also
noteworthy is the minimal postoperative time (lower additional
hours/case) spent with the ENDO patients, which is related to
their predominantly outpatient setting versus the open cases in
Martin’s study (see Table 1 vs. Table 2). Seeger and associates3
called attention to the detrimental effect of additional time spent in
complex postoperative care on physician reimbursement. The
comparison of the two studies emphasizes the influence of proce-
dural time on physician reimbursement per hour, but most impor-
tantly $/RVU, which is at the heart of the question on the validity
of the RBRVS. The better hourly reimbursement for ENDO
emphasizes the disparity of reimbursement to work effort and
becomes more evident when one compares the higher $/RVU for
other general surgical or orthopedic procedures. While the authors
do not state it outright, they imply that one or both of the
components of the work RVU, either time or intensity, may be
overvalued for ENDO. In the budget-neutral world of Centers for
Medicare and Medicaid Services (CMS), what would the authors
have the RUC Committee do – increase the payment for open
procedures or decrease the payment for ENDO procedures?
The revenue from open and endovascular OR procedures
presented in this paper was generated by three vascular surgeonsand one cardiologist, and fromTables 1 and 2 averages $278,102/
physician (open procedure revenue/3 [cardiologist excluded] and
endovascular procedures revenue/4) or $325,159, if restricted
to only the three vascular surgeons. When consideration is given to
physician reimbursement and overhead requirements, an two to
three-fold generation additional generation of revenue per physi-
cian, eg office-based procedures, consults, vascular laboratory,
would be needed.3 This finding emphasizes the important role of
non-OR/interventional suite sources of revenue for the vascular
surgeon and the “real world” difficulty vascular practices face in
generating sufficient revenue from OR/interventional procedures
without extremely high volumes. Imagine what a 21% decrease in
CMS reimbursement, which is before Congress, would do this
revenue data.
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